1-(4-methoxyphenyl)pyridinium has been researched along with cysteamine in 1 studies
| Studies (1-(4-methoxyphenyl)pyridinium) | Trials (1-(4-methoxyphenyl)pyridinium) | Recent Studies (post-2010) (1-(4-methoxyphenyl)pyridinium) | Studies (cysteamine) | Trials (cysteamine) | Recent Studies (post-2010) (cysteamine) |
|---|---|---|---|---|---|
| 55 | 0 | 1 | 3,307 | 60 | 666 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, E; Murai, Y; Oishi, T | 1 |
1 other study(ies) available for 1-(4-methoxyphenyl)pyridinium and cysteamine
| Article | Year |
|---|---|
Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Cysteamine; Dimercaprol; Dopamine; Dopamine Agents; Glutathione; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Nervous System Diseases; Pyridinium Compounds; Sulfhydryl Compounds | 1993 |